Moreover, it has been reported that SRXN1 promotes cell invasion, migration in cervical cancer via activating the Wnt/β-catenin signaling pathway, and could be a promising tool for the development of better therapeutic strategies for cancer prevention and treatment [45]. This evidence concerns the gene SRXN1 and cancer.